|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing bank deposits | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Securities available for sale, at fair value (amortized cost of $6,340,945 and $6,341,322) | ||||||||||||||||||||
| Securities held to maturity (fair value of $1,755,583 and $2,011,026) | ||||||||||||||||||||
| Loans held for sale (includes $42,867 and $33,158 measured at fair value) | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Less: allowance for loan losses | ||||||||||||||||||||
| Loans, net | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $376,395 and $370,818 | ||||||||||||||||||||
| Right of use assets, net of accumulated amortization of $80,695 and $73,527 | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other real estate and foreclosed assets, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Life insurance contracts | ||||||||||||||||||||
| Funded pension assets, net | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Preferred shares authorized (par value of $20.00 per share) | ||||||||||||||||||||
| Common shares authorized (par value of $3.33 per share) | ||||||||||||||||||||
| Common shares issued | ||||||||||||||||||||
| Common shares outstanding | ||||||||||||||||||||
Loading...
